Maximize Beta-Blockers Before Starting Ivabradine
Ivabradine (Corlanor, CORE-lah-nore) will be the first new drug approved for systolic heart failure in a decade.
It works by inhibiting the If or "funny" current in the sinoatrial node. This lowers heart rate...withOUT causing a drop in blood pressure.
Ivabradine prevents 1 in 25 patients from being hospitalized over 2 years...when ADDED to standard therapy including an ACEI or ARB, beta-blocker, and aldosterone antagonist. But it DOESN'T reduce overall mortality.